Quadcap Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quadcap Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$478K	Buy	+631	New	+$477K	0.05%	277

Other funds holding REGN

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Quadcap Wealth Management's REGN Position: Q3 2026 in Review

Quadcap Wealth Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 631 shares worth $478K. The stake represents 0.05% of the portfolio and ranks #277 among its holdings.

725 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

Quadcap Wealth Management held 631 shares of Regeneron Pharmaceuticals worth $478K as of Q3 2026.
Regeneron Pharmaceuticals was a new Quadcap Wealth Management position in Q3 2026.
Regeneron Pharmaceuticals made up 0.05% of Quadcap Wealth Management's portfolio in Q3 2026, its #277 holding.
725 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Quadcap Wealth Management's 13F filing for Q3 2026, filed 2 Nov 2026.